Cystic fibrosis primarily presenting with pseudo-Bartter syndrome: a report of three cases and literature review

ZHANG Ji-Yan; SUN Lin-Jun; DUAN Xiao-Jun; ZHANG Zi-Min; XIAO Zheng-Hui; CHEN Yan-Ping; YOU Jie-Yu

doi:10.7499/j.issn.1008-8830.2310080

PDF(575 KB)

Chinese Journal of Contemporary Pediatrics ›› 2024, Vol. 26 ›› Issue (5) : 506-511. DOI: 10.7499/j.issn.1008-8830.2310080

CLINICAL RESEARCH

Cystic fibrosis primarily presenting with pseudo-Bartter syndrome: a report of three cases and literature review

ZHANG Ji-Yan, SUN Lin-Jun, DUAN Xiao-Jun, ZHANG Zi-Min, XIAO Zheng-Hui, CHEN Yan-Ping, YOU Jie-Yu

Author information +

History +

Abstract

Objective To summarize the clinical characteristics and genetic variations in children with cystic fibrosis (CF) primarily presenting with pseudo-Bartter syndrome (CF-PBS), with the aim to enhance understanding of this disorder. Methods A retrospective analysis was performed on the clinical data of three children who were diagnosed with CF-PBS in Hunan Children's Hospital from January 2018 to August 2023, and a literature review was performed. Results All three children had the onset of the disease in infancy. Tests after admission showed hyponatremia, hypokalemia, hypochloremia, and metabolic alkalosis, and genetic testing showed the presence of compound heterozygous mutation in the CFTR gene. All three children were diagnosed with CF. Literature review obtained 33 Chinese children with CF-PBS, with an age of onset of 1-36 months and an age of diagnosis of 3-144 months. Among these children, there were 29 children with recurrent respiratory infection or persistent pneumonia (88%), 26 with malnutrition (79%), 23 with developmental retardation (70%), and 18 with pancreatitis or extrapancreatic insufficiency (55%). Genetic testing showed that c.2909G>A was the most common mutation site of the CFTR gene, with a frequency of allelic variation of 23% (15/66). Conclusions CF may have no typical respiratory symptoms in the early stage. The possibility of CF-PBS should be considered for infants with recurrent hyponatremia, hypokalemia, hypochloremia, and metabolic alkalosis, especially those with malnutrition and developmental retardation. CFTR genetic testing should be performed as soon as possible to help with the diagnosis of CF.

Key words

Cystic fibrosis / Pseudo-Bartter syndrome / CFTR gene / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHANG Ji-Yan, SUN Lin-Jun, DUAN Xiao-Jun, ZHANG Zi-Min, XIAO Zheng-Hui, CHEN Yan-Ping, YOU Jie-Yu. Cystic fibrosis primarily presenting with pseudo-Bartter syndrome: a report of three cases and literature review[J]. Chinese Journal of Contemporary Pediatrics. 2024, 26(5): 506-511 https://doi.org/10.7499/j.issn.1008-8830.2310080

References

1 囊性纤维化诊断与治疗中国专家共识编写组, 中国罕见病联盟呼吸病学分会, 中国支气管扩张症临床诊治与研究联盟. 囊性纤维化诊断与治疗中国专家共识（2023版）[J]. 中华结核和呼吸杂志, 2023, 46(4): 352-372. PMID: 36990700. DOI: 10.3760/cma.j.cn112147-20221214-00971.
2 Mantoo MR, Kabra M, Kabra SK. Cystic fibrosis presenting as pseudo-Bartter syndrome: an important diagnosis that is missed![J]. Indian J Pediatr, 2020, 87(9): 726-732. PMID: 32504456. DOI: 10.1007/s12098-020-03342-8.
3 Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
4 Chen HJ, Lin SP, Lee HC, et al. Cystic fibrosis with homozygous R553X mutation in a Taiwanese child[J]. J Hum Genet, 2005, 50(12): 674-678. PMID: 16283068. DOI: 10.1007/s10038-005-0309-x.
5 许长礼, 嵇仁祥. 婴儿囊性纤维化合并假性Bartter综合征1例并文献复习[J]. 临床医学研究与实践, 2021, 6(17): 9-12. DOI: 10.19347/j.cnki.2096-1413.202117004.
6 汪东海, 牛超, 代继宏, 等. CFTR基因变异患儿七例基因及临床特征分析[J]. 中华儿科杂志, 2021, 59(8): 689-694. PMID: 34333923. DOI: 10.3760/cma.j.cn112140-20210112-00033.
7 李海燕, 朱婷婷, 陈敏广, 等. 合并假性Bartter综合征的儿童囊性纤维化2例[J]. 温州医科大学学报, 2020, 50(12): 1015-1017. DOI: 10.3969/j.issn.2095-9400.2020.12.015.
8 李志川, 鲍燕敏, 池巧梅, 等. 假性Bartter综合征表现的囊性纤维化2例并文献复习[J]. 中国实用儿科杂志, 2020, 35(2): 147-151. DOI: 10.19538/j.ek2020020615.
9 Qiu L, Yang F, He Y, et al. Clinical characterization and diagnosis of cystic fibrosis through exome sequencing in Chinese infants with Bartter-syndrome-like hypokalemia alkalosis[J]. Front Med, 2018, 12(5): 550-558. PMID: 29520692. DOI: 10.1007/s11684-017-0567-y.
10 Yao Y, Feng XL, Xu BP, et al. Pseudo-Bartter syndrome in a Chinese infant with cystic fibrosis caused by c.532G>A mutation in CFTR[J]. Chin Med J (Engl), 2017, 130(22): 2771-2772. PMID: 29133775. PMCID: PMC5695073. DOI: 10.4103/0366-6999.218015.
11 李冀, 张岩, 王薇, 等. 合并假性Bartter综合征的小儿囊性纤维化1例并文献复习[J]. 山东医药, 2017, 57(4): 48-50. DOI: 10.3969/j.issn.1002-266X.2017.04.015.
12 郭卓瑶, 时艳艳, 钱莉玲, 等. 合并伪Bartter综合征的婴儿囊性纤维化1例病例报告[J]. 中国循证儿科杂志, 2017, 12(6): 471-473. DOI: 10.3969/j.issn.1673-5501.2017.06.014.
13 Shen Y, Tang X, Liu J, et al. Pseudo-Bartter syndrome in Chinese children with cystic fibrosis: clinical features and genotypic findings[J]. Pediatr Pulmonol, 2020, 55(11): 3021-3029. PMID: 32761997. DOI: 10.1002/ppul.25012.
14 张娜, 刘建华, 褚亚娟, 等. 8例囊性纤维化患儿临床及基因突变分析[J]. 中国当代儿科杂志, 2022, 24(7): 771-777. PMID: 35894192. PMCID: PMC9336621. DOI: 10.7499/j.issn.1008-8830.2203015.
15 Shteinberg M, Haq IJ, Polineni D, et al. Cystic fibrosis[J]. Lancet, 2021, 397(10290): 2195-2211. PMID: 34090606. DOI: 10.1016/S0140-6736(20)32542-3.
16 Villanueva G, Marceniuk G, Murphy MS, et al. Diagnosis and management of cystic fibrosis: summary of NICE guidance[J]. BMJ, 2017, 359: j4574. PMID: 29074599. DOI: 10.1136/bmj.j4574.
17 La Bella S, Fiorentino R, Carabotta M, et al. A difficult case of hyponatremic and hypokalemic metabolic alkalosis: answers[J]. Pediatr Nephrol, 2022, 37(12): 3065-3067. PMID: 35579758. DOI: 10.1007/s00467-022-05610-5.
18 中华医学会罕见病分会, 中国研究型医院学会罕见病分会, 中国罕见病联盟, 等. Bartter综合征诊疗中国专家共识（2023）[J]. 协和医学杂志, 2023, 14(4): 744-757. DOI: 10.12290/xhyxzz.2023-0207.
19 Sismanlar Eyuboglu T, Dogru D, ?ak?r E, et al. Clinical features and accompanying findings of pseudo-Bartter syndrome in cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(8): 2011-2016. PMID: 32364312. DOI: 10.1002/ppul.24805.
20 王昊, 徐保平, 申昆玲. 囊性纤维化及中国儿童特点[J]. 首都医科大学学报, 2016, 37(5): 588-592. DOI:10.3969/j.issn.1006-7795.2016.05.006
21 Levento?lu E, Kenan BU, ?ak?r EP, et al. Chronic cough in an adolescent with infantile onset of hypokalemic hypochloremic metabolic alkalosis: answers[J]. Pediatr Nephrol, 2023, 38(4): 1029-1031. PMID: 35723735. DOI: 10.1007/s00467-022-05647-6.
22 Shi R, Wang X, Lu X, et al. A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(11): 3005-3011. PMID: 32716133. DOI: 10.1002/ppul.24980.
23 Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective[J]. Lancet Respir Med, 2020, 8(1): 65-124. PMID: 31570318. PMCID: PMC8862661. DOI: 10.1016/S2213-2600(19)30337-6.
24 中华医学会儿科学分会呼吸学组, 中华医学会儿科学分会呼吸学组疑难少见病协作组, 国家呼吸系统疾病临床医学研究中心, 等. 中国儿童囊性纤维化诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37(22): 1681-1687. DOI: 10.3760/cma.j.cn101070-20220504-00495.
25 Shen Y, Tang X, Chen Q, et al. Genetic spectrum of Chinese children with cystic fibrosis: comprehensive data analysis from the main referral centre in China[J]. J Med Genet, 2022, 60(3): 310-315. PMID: 35858753. PMCID: PMC9985745. DOI: 10.1136/jmg-2022-108501.
26 Tian X, Liu Y, Yang J, et al. p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis[J]. Hum Genome Var, 2016, 3: 15063. PMID: 27081564. PMCID: PMC4785583. DOI: 10.1038/hgv.2015.63.
27 杜之傲, 孙慧明, 陈正荣. 囊性纤维化并假性Bartter综合征研究进展[J]. 中华实用儿科临床杂志, 2022, 37(22): 1727-1729. DOI: 10.3760/cma.j.cn101070-20220130-00118.
28 Kintu B, Brightwell A. Episodic seasonal pseudo-Bartter syndrome in cystic fibrosis[J]. Paediatr Respir Rev, 2014, 15 Suppl 1: 19-21. PMID: 24821548. DOI: 10.1016/j.prrv.2014.04.015.
29 Clain J, Fritsch J, Lehmann-Che J, et al. Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function[J]. J Biol Chem, 2001, 276(12): 9045-9049. PMID: 11118444. DOI: 10.1074/jbc.M008979200.
30 Macek M, Hamosh A, Kiesewetter S, et al. Identification of a novel nonsense mutation (L88X) in exon 3 of the cystic fibrosis transmembrane conductance regulator gene in a native Korean cystic fibrosis chromosome[J]. Hum Mutat, 1992, 1(6): 501-502. PMID: 1284542. DOI: 10.1002/humu.1380010608.
31 Ferec C, Cutting GR. Assessing the disease-liability of mutations in CFTR[J]. Cold Spring Harb Perspect Med, 2012, 2(12): a009480. PMID: 23209179. PMCID: PMC3543074. DOI: 10.1101/cshperspect.a009480.
32 Fustik S, Pop-Jordanova N, Slaveska N, et al. Metabolic alkalosis with hypoelectrolytemia in infants with cystic fibrosis[J]. Pediatr Int, 2002, 44(3): 289-292. PMID: 11982899. DOI: 10.1046/j.1442-200x.2002.01563.x.
33 Guo X, Liu K, Liu Y, et al. Clinical and genetic characteristics of cystic fibrosis in Chinese patients: a systemic review of reported cases[J]. Orphanet J Rare Dis, 2018, 13(1): 224. PMID: 30558651. PMCID: PMC6296146. DOI: 10.1186/s13023-018-0968-2.
34 Abdul Aziz D, Siddiqui F, Abbasi Q, et al. Characteristics of electrolyte imbalance and pseudo-Bartter syndrome in hospitalized cystic fibrosis children and adolescents[J]. J Cyst Fibros, 2022, 21(3): 514-518. PMID: 34610890. DOI: 10.1016/j.jcf.2021.09.013.